臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 111-135 / 1137 (共46頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-06-27T06:59:56Z	IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer	Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; Chang Y.-L.; CHONG-JEN YU; Shih J.-Y.
臺大學術典藏	2022-06-27T06:59:55Z	Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma	Yang C.-Y.; Hsieh M.-S.; Liao W.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:53Z	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations	Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:52Z	A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor	Chen L.-C.; Shih J.-Y.; CHONG-JEN YU; Yang C.-Y.
臺大學術典藏	2022-06-27T06:59:51Z	Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors	Chang L.-C.; Lim C.-K.; Chang L.-Y.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:51Z	Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients	Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:49Z	Effectiveness of Treatments for Advanced Non–Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations	Wu J.-Y.; CHONG-JEN YU; Shih J.-Y.
臺大學術典藏	2022-06-27T06:59:49Z	Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors	Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; Shih J.-Y.; CHONG-JEN YU; Chen K.-Y.; Tsai T.-H.; Yang J.C.-H.
臺大學術典藏	2022-06-27T06:59:49Z	Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study	Chen Y.-H.; Chen Y.-F.; Chen C.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:47Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:46Z	The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation	Wu S.-G.; CHONG-JEN YU; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏	2022-06-27T06:59:44Z	Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer	Yang W.-C.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; CHONG-JEN YU; Lin Z.-Z.; Lu S.-H.; Yang J.C.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2022-06-27T06:59:44Z	Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer	Lin Y.-T.; Tsai T.-H.; Wu S.-G.; Liu Y.-N.; CHONG-JEN YU; Shih J.-Y.
臺大學術典藏	2022-06-27T06:59:43Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:43Z	Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma	Lu H.-H.; Lin S.-Y.; Weng R.R.; Juan Y.-H.; Chen Y.-W.; Hou H.-H.; Hung Z.-C.; Oswita G.A.; Huang Y.-J.; Guu S.-Y.; Khoo K.-H.; Shih J.-Y.; CHONG-JEN YU; Tsai H.-C.
臺大學術典藏	2022-06-27T06:59:41Z	Clinical factors associated with treatment toxicity of pemetrexed plus platinum in elderly patients with non-small cell lung cancer	Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:40Z	Effect of β-Blocker in Treatment-Na?ve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs	Chang C.-H.; Lee C.-H.; Ko J.-C.; Chang L.-Y.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:39Z	Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life	Hsieh C.-C.; Ho C.-C.; Lin Z.-Z.; CHONG-JEN YU; Jow G.-M.; Huang F.-Y.; Shih J.-Y.; Hsiao F.-H.
臺大學術典藏	2022-06-27T06:59:38Z	Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC	Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; CHONG-JEN YU; Soo R.A.; Yang J.C.-H.
臺大學術典藏	2022-06-27T06:59:38Z	Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort	Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:37Z	Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan	Wu S.-G.; Liao W.-Y.; Su K.-Y.; Yu S.-L.; Huang Y.-L.; CHONG-JEN YU; Chih-Hsin Yang J.; Shih J.-Y.
臺大學術典藏	2022-06-27T06:59:37Z	Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1	Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; Shih J.-Y.; Chang Y.-L.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:35Z	Establishing aspergillus-specific igg cut-off level for chronic pulmonary aspergillosis diagnosis: Multicenter prospective cohort study	Lee M.-R.; Huang H.-L.; Keng L.-T.; Chang H.-L.; Sheu C.-C.; Fu P.-K.; Wang J.-Y.; Chong I.-W.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:33Z	Tyrosine kinase inhibitors improved survival of critically ill egfr-mutant lung cancer patients undergoing mechanical ventilation	Lee I.-H.; Yang C.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:31Z	The Long-Term and Mediating Effects of Mindfulness Integrated with Body-Mind-Spirit Group Therapy on Depressive Symptoms and Quality of Life Among Non-small Cell Lung Cancer Patients	Hsiao F.-H.; Lin Z.-Z.; Huang F.-Y.; Lai Y.-M.; Chen Y.-T.; Shih J.-Y.; Ho C.-C.; CHONG-JEN YU; Hsieh C.-C.

顯示項目 111-135 / 1137 (共46頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52842075 線上人數 : 697 教育部委託研究計畫計畫執行:國立臺灣大學圖書館